INTRODUCTION
The development of the Treponema pallidum haemagglutination assay (TPHA) in the mid-1960s1,2 led to its widespread use in Europe as a screening test, usually in combination with a cardiolipin antigen test 3-5. This combination was acknowledged as giving the best coverage for detection or exc~usion of all forms of treponemal infection", and m t.he United Kingdom in 1983, 86% of laborat?nes participating in the United Kingdom (UK) National External Quality Assessment Scheme for Microbiology employed this screening protocol>. In contrast to the stability in test protocols there was a marked change in the epidemiology of early syphilis with a significant overall decline in incidence in the United Kingdom starting in the late 1970s ( Figure 1 ). As a result of this decrease the value of traditional routine testing of certain populations such as pregnant women" and blood donors 7 has been questioned.
Over the past few years the situation has changed and we have witnessed important potential developments in the diagnosis of syphilis's? as well as a renewed interest in many aspects of the disease itself lO - 14. Factors associated with this renaissance include: interactions between syphilis and infection with the human immunodeficiency virus (HIV) 15-21; changes in the epidemiology of early syphilis 22-25 production of pathogen-specific monoclonal antibodies 26-30 ; I?rod.uction of tre~one~al antig.e~~_~l genetic recombination and clonmg m bacteria-, development of new assay formats such as enzyme immunoassay (EIA) applicable to large-scale screening and automation'" as well as methodologies such as immunoblotting [35] [36] [37] and .the polymerase chain reaction (PCR)38-40 more suited to confirmatory testing and problem cases.
The aim of this review is to examine how these factors have already impinged on our approach to diagnosis, or are likely to do so in future, and~o reassess the value and limitations of conventional diagnostic tests and strategies as a baseline against which to evaluate new approaches.
IMPORTANCE OF HIV

Increased transmission
A genital ulcer disease such as syphili~which disrupts the integrity of the mucosal epithelium may increase susceptibility to HIV17, 41-43. As the base of a genital ulcer is likely to contain large numbers of activated lymphocytes and macrophages it provides not only a source of target cells for HIV acquisition but may also enhance transmission of HIV to uninfected sex partners via antigenic stimulation of latently HIV-infected cells resulting in activation and liberation of HIV42. There is some experimental evidence to suggest that rabbits infected with human T-cell leukaemia virus type I show protracted T. pallidum induced cutaneous chancres": by analogy infection with HIV could lead to delayed healing of chancres thus increasing an individual's infectivity in the case of syphilis. Control of genital ulcer disease including syphilis is therefore important in the control of HIV41,42. It is recommended that every patient with positive syphilis serology should be tested for HIV (with the patient's informed consent) and that every HIV-positive patient should be tested for syphilis".
Serodiagnosis
The finding that HIV-infected patients who acquir.e syphilis may fail to produce anti-treponemal antibodies19,46 has extremely serious implications for the diagnosis and control of syphilis; certain of the patients described as seronegative are however more accurately classified as 'delayed seropositivity'P. Nevertheless this finding increases the importance of demonstrating T. pallidum in tissues as a means of diagnosing early syphilis". Fortunately the vast majority of HIV-infected patients who acquire syphilis appear to have a normal serological response to T. pallidum 15 ,45 . Indeed many HIV infected patients who acquire syphilis produce very high levels of anti-treponemal entibodiesl'': this may be a result of polyclonal B-cell activation but the fact that many such patients are likely to be experiencing re-infection with syphilis'" might also contribute to high antibody levels. However, Hutchinson et al. 49 found that in patients with secondary infection and no previous syphilis the geometric mean RPR titres were significantly higher among HIV-seropositive patients than in HIVseronegative patients.
Serological tests for monitoring therapy
The possibility that polyclonal B-cell activation might interfere with the reliability of treatment monitoring by quantitative cardiolipin tests has also been considered. Terry and colleagues'" found that coexisting HIV infection had no influence on posttreatment titres, at least when patients were in the early stages of HIV infection. A second report''! found that HIV-infected patients with primary syphilis when compared with HIV-negative controls were less likely to have a 4-fold or greater decrease in cardiolipin antibody titre, or seroreversion, within 6 months of treatment. Cases and controls with secondary syphilis had similar serological responses after treatment for syphilis'". Further studies are obviously required to determine definitively whether HIV alters the serological response to therapy in patients with early syphilis.
Serological markers for past syphilis
It is, however, becoming increasingly apparent that serological evidence of treated syphilis may disar£ear after patients become infected with HIV ,52. Specific antibody was undetectable in up to 10% of AIDS patients who previously had positive tests. Loss of treponemal antibody response has been noted within 2 years of treatment for secondary syphilis and before the onset of AIDS53. In this case the loss of antibody response was not linked to serious humoral immune deficit since IgG responses to other infections such as rubella, cytomegalovirus, haemolytic streptococci, and staphylococci remained detectable. Clearly there is a reduction in levels of specific anti-treponemal antibody to T. pallidum in some HIV-infected individuals as they progress through their illness. This means that negative specific serology does not necessarily exclude a past syphilis infection in patients with AIDS; the significance of this in relation to differential diagnosis in patients with neurological problems is not yet known. It also makes it important that new tests are evaluated for sensitivity and specificity against HIV-infected patients. There is some evidence that nontreponemal tests may yield high titres (> 16)in HIVinfected patients without syphilis 54 • Alterations in the natural course of syphilis There are an increasing number of reports to suggest that in HIV-infected patients syphilis runs a more severe course and lesions may be more~ §:essive in both early55,56 and late stage disease ' . Neurological complications of secondary syphilis occur more frequently and at an earlier stage 18,59 and may increase the risk of treatment failure 13 ,60. Ocular symptoms are h~ortant in HIVinfected patients with syphilis 61-and in some cases their investigation has led to the diagnosis of syphilis 65 ,66. There is of course a considerable clinical overlap between the two infections with reports of secondary syphilis masquerading as AIDS67 and primary HIV infection mimicking syphilis 68 • CHANGES IN EPIDEMIOLOGY Figure 1 shows the changing incidence of early syphilis in the United States, England and Wales, and Scotland. At the time of the peak levels of syphilis in the late 19708 in the United Kingdom and around 1982 in the United States the majority of cases of early infection were homosexually acquired 69-72 and the overall decrease observed was associated with a decrease in homosexuallyacquired syphilis which has been reported in the United Kingdom73,74, the Netherlands-t, Sweden'", Denmark'", Canada'? and the United States 69,70.
Increase in heterosexual transmission
The marked increases observed recently in the United States have been associated with heterosexual transmission, drug abuse, and prostitution 69,78-so and syphilis, along with gonorrhoea and chancroid, is 'especially rife in the nation's poverty pockets'f". With 50,223 cases reported in 1990 (a 9% increase over 1989) syphilis is now at its highest level since 19498 2 : the incidence of 20 cases per 100,000persons represents a 75% increase from 1985and is well adrift from the 1990 objective of 7 cases per 100,000 population. There have also been reports of a resurgence in heterosexually-acquired infection in areas of London-" as well as in Amsterdam-" and in the province of Manitoban. In general, however, the level of early syphilis is low in Europe and this means that clinical and laboratory experience with respect to diagnosis, particularly primary infection, is limited among younger doctors.
Congenital infection
In the USA there has been a dramatic spill over into the child-bearing population with between 17 and 1~cases of congenital infection per 1,000,000 live blrths in 1988, again outstripping the 1990 objective of 1.5 cases per 100,000 live births 83 • Levels in certain cities such as New York are even higher84.
lthough the overall trend in the United Kingdom IS a decline, between 1985 and 1986, there was a small increase in syphilis in young women with a concomitant increase in congenital infection from 3 cases in 1985 to 9 in 1986 85 •
DIAGNOSIS
As it is impossible to culture T. pallidum in vitro serological tests are the mainstay for the diagnosis of syphilis at all stages, other than, perhaps, the very early stages of the disease. T. pallidum may be detected, usually by microscopy, in the genital and rectal lesions of primary syphilis. In many cases this enables a diagnosis of primary syphilis to be made rapidly in the absence of reactive serology. A ffilcroscopic diagnosis of primary syphilis depends on the skill of the clinician in obtaining a specimen as. well as expertise in darkfield microscopy. M~croscopy is not suitable for examining the dry skin r.ashof secondary syphilis, but treponemes are plentiful in the moist lesions at mucocutaneous junctions, such as mucous patches or condylomata lata'.Demonstration of T. pallidum in biopsy material has Increased considerably in importance since the reports of seronegative syphilis in association with HIV infection 19 In the normal flora of the genital and rectal mucosal surfaces (because of interference from commensal sPi.rochaetes darkfield microscopy may not be rel~able in the case of rectal and non-penile genital eSlO~s); maintaining viability means that potentially infectIous specimens, possibly containing HIV, must be examined within 10-30 min; accurate interpretation of darkfield microscopy is dependent on a~ighly experienced observer-the decrease in prImary syphilis means that experience in dark ground microscopy is limited; oral lesions normally abound with commensal treponemes and cannot be reliably examined; darkfield microscopes are 
Immunofluorescent staining
The direct fluorescent-antibody staining for T. In one study89 the DFA-Tp test using monoclonal antibody H9-1 evaluated on ulcer material from 30 patients with and 31 without syphilis was 100% sensitive and specific; darkfield microscopy was 97% sensitive and 77% specific. In a series of 66 patients with and 62 without syphilis the same test gave a sensitivity of 73% and a specificityof 100%; darkfield microscopy was 79% sensitive and 100% specific 222 • The test would therefore appear to be as sensitive as darkfield microscopy and of greater potential specificity. Like darkfield microscopy the test is also subject to sampling variation and obstruction of treponemes by debris and erythrocytes and lesions should be examined on three consecutive days before being considered negative. Because of the advantages described above, if the monoclonal antibody DFA-Tp test becomes widely available commercially, it may make darkfield microscopy redundant. A further potential advantage is the ability to examine lesion exudate simultaneously for other genital pathogens such as herpes simplex viruses and Haemophilus ducreyi.
EIA
The Visuwell" Syphilis Antigen EIA is a recently introduced commercially available (ADI Diagnostics, Canada) alternative to microscopy for detecting T. pallidum in early lesions. Antigen extracted from lesion material collected on a swab is captured by a pathogen-specific monoclonal antibody reactive with a 47 kD protein and detected by rabbit polyclonal antibody against T. pallidum. The presence of captured antigen is demonstrated by a goat anti-rabbit urease conjugate. The test yields a visually distinct endpoint and requires about one hour to run. A preliminary evaluation'? reported a sensitivity of 64% (42/66) compared with 53% (35/66) for darkfield microscopy; 28 specimens were positive by both methods, 7 by darkfield only, 14 by EIA only, while 17 were negative by both methods. EIA was positive in 24% (11/45) of patients with non-syphilitic lesions of uncertain diagnosis; 3 of these patients subsequently seroconverted increasing the specificity to 82% (37/45): darkfield was 100% specific. A modified extraction procedure and results corrected for equivocal data increased EIA sensitivity to 76% (darkfield also increased to 76%) and specificity to 91% (manufacturer's product data).
Although EIA is sensitive, needs little expertise and costly equipment, lack of specificity would appear to be a major problem. The implications of a diagnosis of primary syphilis are such that specificity must be paramount. In examining material from genital ulcers the technical disadvantages of immunofluorescence are more than outweighed by the ability to observe organismal morphology.
Identification of T. pallidum in tissues
The report that the diagnosis of secondary syphilis in an HIV infected man with Kaposi sarcoma required biopsy of a skin lesion with silver staining to show splrochaetes'? re-awakened interest in this form of diagnosis. The Centers for Disease Control (CDq, Atlanta recommend that when clinical findings suggest syphilis, but serological tests are negative, biopsy tissue should be examined by DFATp or silver staining (Warthin Starry Silver, Steiner)?'. A caution is given, however, with regard to the occurrence of artifacts and interpretation of silver staining'": problems are most likely to arise when few organisms are seenmany normal tissue components, such as collagen, are also stained and may be easily confused for spiral organisms'".
Silver Dental plaque from healthy subjects and from patients with ulcerative gingivitis or chronic periodontitis was examined by an immunocytochemical technique using monoclonal antibodies against pathogen-specific determinants on 47 kD and 37 kD molecules from T. pallidum subspecies pallidum 95 . The results showed that the spirochaetes found in dental plaque from diseased, but not healthy, patients have antigens that are thought to be unique to pathogenic treponemes. They concluded that this close antigenic relationship suggested that T. pallidum or a closely related organism may be involved in the pathogenesis of periodontal disease. Many patients also had detectable IgG against the pathogen-specific molecules. The significance of these findings for diagnostic methods based on pathogen-specific antigens and monoclonal antibodies obviously requires evaluation and the possibility of current or recent periodontal disease should be kept in mind in the case of inconsistent findings.
SEROLOGICAL SCREENING AND
SERODIAGNOSIS
Serological tests which form the mainstay of diagnosis beyond the primary stage are best considered in relation to the natural history of infection and the humoral immune response.
Natural history of untreated syphilis
The natural course of syphilis may span several decades and can present in a variety of clinical forms 97.98. The prepatent period is usually about 25 days (range 9-90 days). If untreated, primary lesions will normally heal in 3-8 weeks and the disease will progress to the secondary stage, usually 6-12 weeks after contact, but occasionally as long as 12 months. Once the early infectious stage of the disease has run its course it enters the late non-infectious stage about 2 years after the initial contact. This latent (or 
USE OF SEROLOGICAL TESTS
The way in which the main serological tests are used is outlined in Table 1 . In this discussion the term screening is used to refer to both ' screening' and I case-finding' activities as is standard practice in most publications on syphilis serology. In the strict sense screening is the testing of apparently healthy volunteers from the general population for the purpose of separating them into groups with high and low probability for a given disorder whereas case-finding is a form of disease detection in which individuals seeking health care for any reason are given additional tests to detect a disease such as syphilis 105 .
Basically syphilis serodiagnosis depends on the principle of dual level testing. Because of the low bands including the 12 kD molecule. In secondary and early latent syphilis the main serological response is associated with antigens of 12, 14, 33, 37, 42 and 47 kD. In late latent syphilis reactivity against the 47, 14 and 12 kD antigens predominates but there is a decreased spectrum and intensity of IgG reactivity9,lOO. Therapeutic intervention at any stage of the disease causes a generalized loss of antibody against individual antigens; the rate and degree of this loss is inversely proportional to the duration of symptoms and the stage of the disease before therapy. HIV infection may also have a significant effect on the spectrum of antibodies produced. Western blot analysis of serum from a patient with secondary syphilis and asymptomatic HIV showed antibodies to far fewer antigens than are usually present in secondary sera 56: only three bands including that to the 47 kD antigen appeared to be of appropriate intensity.
The complexity of the immune response poses a considerable serological challenge and it is surprising that existing serological tests perform as well as they do. The complexity of the immune response poses considerable problems with regard to the use of serological tests based on single recombinant antigens. In a recent studyl02 nine pathogen-specific polypeptides (15, 17, 33, 37, 39, 43, 45, 47, 49 kD) ere commonly recognized by the time chancre Immunity developed-minor differences in the molecular masses of some of these antigens have been described by different investigators'P'.
In primary infection a strong antibody response to a 48 kD band was reported by Baker-Zander and COlleagues lOO as well as reactivity against 6 other hidden) stage may persist for the remainder of an individual's natural life but on the other hand, the d~sease may, after several years or even decades, grve rise to gummatous lesions. (15%), cardiovascular (10%) or neurological (8%) disorders".
Adequate treatment during the early stages will prevent development of late-stage infection (see l~po~ance of HIV under neurosyphilis however). LikewIse detection and treatment of latent stage inf~ction when there are no symptoms will prevent active infection which will otherwise develop in about one-third of patients. From the serological p~>lnt of view it is important to appreciate that different serological tests vary widely in their ability to detect latent infection and this must be taken into account in considering screening policies. Patients are diagnosed with latent infection who are completely unaware of having experienced primary or secondary symptoms. Antibiotics prescribed for ?ther. conditions may abort or delay early stage infection, minimizing or abolishing early symptoms. U~ortunately we have no serological test to identify which patients with latent infection will develop symptoms.
prevalence of infection, poor positive predictive values can result even when tests of high specificity (>99%) are used for screening. For example a test with 99% specificity has a positive predictive value of only 50% when the prevalence of syphilis is 1% but 91% when prevalence rises to 10%. Traditionally sera selected on the basis of a reactive screening test are checked by a confirmatory method in order to establish the treponemal nature of antibodies detected by the screening test. Screening therefore has the effect of increasing the prevalence of the disease in the reactive population. In the example given above screening has increased the prevalence of disease from 1% in the initial population to 50% in the confirmatory population and the use of a second (confirmatory) test of the same specificity (99%) increases the positive predictive value to 98% (ie only two of 100 patients with reactive sera will not have syphilis). It follows, however, that the confirmatory test must have as high a sensitivity as the screening method otherwise sera may be classified falsely as non-treponemal (this possibility is discussed under confirmatory tests).
Once sera are confirmed as treponemal, quantitative tests and/or detection of specific anti-treponemal IgM may help assess treatment status and monitor the efficacy of therapy. Laboratories performing confirmatory tests should also be able to assist with special problems such as the diagnosis of congenital infection and neurosyphilis. Not all laboratories need perform the full array of tests and it is common for sera reactive on screening (eg in a blood transfusion centre or a laboratory serving an antenatal clinic) to be referred for confirmatory testing.
Screening tests
There are three main choices: a cardiolipin antigen test; a T. pallidum antigen test; a combination of both. It is not the purpose of this review to cover details of these tests which have been reviewed elsewhere 86 ,99 but to summarize the advantages and disadvantages of these approaches.
Cardiolipin antigen tests
Tests such as the Venereal Diseases Research Laboratory (VDRL) or Rapid Plasma Reagin (RPR) test are cheap, simple and quick to perform and can be adapted for automated testing as in blood transfusion centres. The RPR test is more suitable for large numbers of sera106. In general, all behave in a similar manner with regard to the spectrum of antibodies detected. Antibody becomes detectable 7-10 days after the appearance of the primary chancre or 3-5 weeks after acquiring the infection. Sensitivi~ranges from 60 to 87% in primary infection and may reach 100% in the secondary stage. Titres decline beyond the secondary stage and around 30% of patients with late syphilis are nonreactive?'. Cardiolipin antigen tests also tend to become negative after treatment.
Cardiolipin tests such as the VORL when used alone provide an effective screen for early infection only and are often used in areas of high prevalence and limited resources. The RPR is particularly suitable as an immediate test and has been advocated for testing of pregnant patients, who have had no prenatal care, when presenting at an emergency department with any complaint, in the hopes of reducing the incidence of congenital syphilis l O7 • Disadvantages of cardiolipin antigen tests include the occurrence of BiologicalFalse Positive Reactions (more accurately described as a non-treponemal cardiolipin response's) in around 0.3-0.9% of all sera examined. The most serious, and often underestimated, disadvantage is the occurrence of the prozone phenomenon: Le. false negative reactions resulting from inhibition of agglutination due to excess antibody in the serum. The prozone phenomenon is generally considered to occur in 1-2% of patients with secondary syphilis 99 ,l 08. This may be an underestimate: Spangler et aI.IOB reported 24 patients in various stages of infection whose serological tests were negative; 16 of the 24 negative tests were due to the prozone phenomenon. A policy of performing a quantitative VDRLtest on any serum giving a TPHA titre> 5120 resulted in a prozone rate of 8% in patients with seconda:1o and 10% in patients with early latent . infection 03.
The tendency of the prozone phenomenon to occur in sera with high VDRL titres could be particularly important in patients with concomitant HIV infection as sera from many such patients have unusually high antibody levels 15 ,l oq. Unusually high titres are also found in patients undergoing reinfection, even in cases of primary syphilis 103 ; the increased risk of the prozone phenomenon occurring in sera from these patients makes detection of re-infection by non-treponemal tests less reliable. False negative VORLreactions may also occur in the cerebrospinal fluid (CSF). Feraru et aI.I09 reported 2 HIV positive patients with neurosyphilis whose initial CSF VORL tests were negative. In one of these patients the initial negative VDRL test m~have been due to the prozone phenomenon 1 . False negative results are important in antenatal screening. Recently 4 cases with false negative serological tests due to the prozone phenomenon were encountered in women who gave birth to infants with congenital infectionll". In another report there was a failure to diagnose syphilis at birth in 7 infants 11l ; 4 mothers and their infants had given negative qualitative RPR tests at delivery while 3 mothers had tested RPR negative during pregnancy and were not tested at delivery. Although serum dilution prior to testing was recommended as a routine procedure for all seronegative women in an area of high syphilis prevalence'P this is not a practical solution when all patients can be screened simply and reliably with specific anti-treponemal antibody tests such as the TPHA or EIA.
These findings suggest that, because of the prozone phenomenon, cardiolipin tests based on agglutination should not be used alone to screen for untreated early infection. As the RPR test is very rapid it is ideal for use in emergency departments 107 ,l12 . In these circumstances diluted as well as undiluted serum should be tested as part of the standard procedure. EIA using cardiolipin antigen 113 ,114 should overcome the problems of the prozone reaction but would still represent a poor screen for late infection.
Screening with a combination of cardiolipin and T. pallidum antigen tests
The activities of the TPHA and VORL tests are complementary and the combined use of the two tests provides an excellent screen for the detection or exclusion of syphilis at all stages 4 ,5. TPHA reactivity may be detectable around the 4th week of infection. The sensitivity in untreated primary i~ection ranges from 64% to 87%30. The TPHA t~tre tends to be low in primary syphilis (80-320) but nses sharply in the secondary stage reaching 5120 Or greater. The titre declines during the latent stage but invariably remains positive, often at low titre (80-1280). Titres may decline after therapy but, with the exception of patients co-infected with HIV115, the test almost always remains positive.
According to Luger'? the TPHA, with an overall margin of error in the range of 0.07% false positive reactions and 0.008% false negative reactions, is the most sensitive and specific method for detecting antibodies to T. pallidum. When false negative reactions occur they are usually associated with early primary infection and this is the main reason why the TPHA has not been widely used as a single screening test in laboratories serving STO clinics. Serological detection of primary syphilis is increased by the combination of tests as they are co~plementary in their activity with regard to pnmary syphilis 103: e.g. the VORL test gave a sensitivity of 72.7% compared with 70.5% for the TPHA whereas the two tests gave a combined sensitivity of 84.1%. Although several studies have suggested that antibody detected by the TPHA appears later, or is of relatively lower titre, than that detected by cardiolipin antigen tests 86 in one large retrospective analysis of routine practice !he TPHA gave a sensitivity of 74.9% (487/659) 10 primary infection compared with 70.4% for the VORL116. In using the combination of tests, part from increasing the detection of primary 1Ofection, the TPHA will detect high titre sera that may give a false negative reaction due to the prozone phenomenon.
Therefore although the test combination can not be faulted with regard to performance data, it equires more labour than does a single test, Interpretation is subjective, and the combination does not lend itself readily to automation. Preliminary evaluations of a commercially available EIA (Captia Syphilis G) gave high sensitivity in detecting anti-treponema! antibody in untreated as well as treated infection 34 ,123 . Because the sensitivity in detecting untreated primary infection was 82%(14/17) (88.2% if equivocal results were scored positive as would happen on screening) compared with 100% for all other stages of infection, Lefevre et al. 123 considered that this EIA was unsuitable as a replacement for the VORL and TPHA screening combination. A retrospective analysis of routine screening results l O3 showed that a sensitivity of 82% in detecting untreated primary infection is greater than any other single test including dark ground microscopy (76%), VORL (73%), TPHA (71%) and the fluorescent treponemal antibody absorbed (FTA-abs) test (80%). Similar sensitivities for dark ground microscopy (78%), VORL (70%) and TPHA (75%) in untreated primary syphilis have also been found in large scale evaluations of clinical practice 116 • Although the combination of VORL and TPHA tests did give slightly greater sensitivity103 (84%) this value was not significantly different (P>0.8) from the 82% sensitivity of Captia Syphilis G123.
There is no evidence to suggest that, in the case of primary syphilis, screening for anti-treponemal IgG by EIA is significantly less sensitive than the combination of VORL and TPHA tests. Provided « that clinicians are aware of the 'seronegative window' that may exist for 1-2 weeks during the early primary infection, maintain a high index of clinical suspicion and have the facility to request additional tests (e.g. specific IgM or FTA-abs) in cases of suspect primary infection, then detection of early infection will not be compromised by using anti-treponemal IgG EIA as a sinfle screening test. A proportion, 11%103 to 14.5%11 of cases of early primary syphilis are seronegative in all tests at the time of presentation. A high index of clinical suspicion is the key factor in making a diagnosis of primary infection and is probably more important than the serological screening schedule used. Syphilis remains a situation where very large numbers of specimens are examined in order to detect a very small number of positive findings. In these circumstances new methods such as EIA with the potential for automated testing and computerised reporting have many attractions.
Other EIAs
A competitive EIA for Treponema pallidum antibodies (CETPIA) has been produced 'in-house' at the Public Health Laboratory, Newcastle upon Tyne 124. Preliminary analysis suggests that the assay has high sensitivity and specificity. An EIA based on purified axial filaments of the reiter treponeme (AF-ELISA) was compared with an EIA using an ultrasonicate of T. pallidum (TP-ELISA)l25; both assays were prepared 'in-house'. At all stages of syphilis the sensitivity of the TP-ELISA, the AF-ELISA, the TPHA and the FTA-abs test did not differ significantly, except that the AF-ELISA was less sensitive than the TPHA for treated syphilis.
As far as the author is aware none of the above EIAs are available commercially althou~h an EIA based on a recombinant antigen TmpA 26 is. The TmpA EIA gave a sensitivity of 76% for primary syphilis, 100% for secondary, and 98% for early latent infection but has not been evaluated in late infection 126. These EIAs require more detailed evaluation before their role in syphilis serology can be assessed in relation to existing strategies.
Screening policies: population groups and tests
Although the role of antenatal screening has been questioned" the overwhelming body of opinion is that routine antenatal screening for syphilis is not only cost-effective but is a valuable public health measure that must continue, even in countries in which the disease has a relatively low prevalence127-133. Likewise, opinion favours maintaining syphilis screening of blood donations l34-136 although there is some debate regarding which tests should be used": tests such as the VORL tend to be used in the United States, France, and Belgium whereas in other countries such as Germany, the Netherlands, and the UK, the TPHA is often used for screening. Routine screening also has a role in certain hospitalized grpups such as psychogeriatric patients 137 and those who are alcohol or drug abusers-". It was advocated that all patients admitted to hospital with a neurological or psychiatric disorder should have syphilis serology checked as a routine, though it was not considered necessary to perform tests routinely on outpatients-": Others have questioned the value of routine screening of psychogeriatric patients l40 and it is clear that detailed further investigation of patients is required if routine blood screenin? is to be justified and of value in management 137,14 . The recent increase of early syphilis has highlighted the need for syphilis serology as part of a rapid serological screen in emergency departments 107,112.
In Europe it is generally accepted that the additional cases of late syphilis, including late latent, detected by screening with T. pallidum antigen tests outweighs the difficulties that may arise in differentiating between inadequately or untreated patients and those who have a well documented history of appropriate therapyl42,l43. A careful examination of 53 individuals with negative VORL but reactive TPHA on screening revealed mesaortitis in 4 and neurosyphilis in 2 patients'". Gormsen144 found that half of 97 patients with syphilitic aortitis (diagnoses confirmed at autopsy) were negative in the VORLtest. Whilst it is accepted that these are highly selected groups they nevertheless emphasize the importance of screening with T. pallidum antigen tests.
In the United States, however, treponemal tests are considered as confirmatory tests and screening relies mainly on cardiolipin tests. Indeed the case definition of latent syphilis used for public health surveillance is given as 'no past diagnosis of syphilis and a reactive nontreponemal test, and a reactive treponemal (fluorescent treponemal antibodyabsorbed [FTA-ABS]) microhaemagglutination assay for antibody to Treponema pallidum [MHA-TPJ test'145. The finding that HIV-infected patients who acquire syphilis may fail to produce antitreponemal antibodies 19,46 combined with the tendency for serological evidence of treated syphilis to disar~ear after patients become infected with HIV20,5 ,3 may act as a stimulus for the more widespread adoption of testing with T. pallidum antigen tests.
Confirmation
The Treponema pallidum immobilization (TPl) test
Once the only reliable test for distinguishing between treponemal and non-treponemal cardiolipin-antibody responses, the TPI test has now been superseded by the widespread use of the PTAabs test 146. The need to improve FTA-abs test performance rather than rationalize its deficiencies was also stressedlw. The TPI test may be negative in primary infection and this is a cause of discrepancies between TPI and FTA-abs test resultsr". The FTA-abs test is not only more sensitive than the TPI in all stages of untreated infection it also remains positive longer after treatment accounting for the view that the TPI fails to provide useful diagnostic informationlv'. The main role of the TPI nowadays is for research purposes.
FTA-abs
The FTA-Abs is currently the standard confirmatory test. It becomes reactive around the third week of infec~ion and in primary infection has a sensitivity rangmg from 86% to 100%. It is positive in all secondary cases and 96-100% of late stage infections 30 • Reactivity persists after adequate therapy although the test may occasionally become non-reactive if treatment is given early in the disease.
Most laboratories use commercial kits for performing the FTA-abs test and this is an area where much greater standardization is required. The ability of four different kits to detect reactive samples varied from 83% to 95%, and the agreement with non-reactive and borderline samples ranged from 81% to 96.4%149. In another study, agreement between 4 kits was 63% for treponemal sera and 50% for non-treponemal sera ISO. Discrepancies with treponemal sera were associated with low levels of antibody characterized by TPHA titres~160 and a negative VDRL test. Discrepancies with nontreponemal sera were significantly associated with false reactivity on screening with EIA.
The FTA-abs is considered to be a very specific test. However, the test is not endowed with the high level of specificity usually accorded. The reputation for~igh specificity stems from the principle of dual testing described earlier, ie the FTA-abs is used to test sera that have been pre-selected thus increasing considerably the probability that they contain antitreponemal antibodies. The specificity of the FTAabs test is not absolute, however, and varies from 92% to 99%151. The total prevalence of false r~activity is around 1% in normal persons, but hlg~er rates have been reported in hospital pattents 99 . It has been estimated that at a prevalence of syphilis of 1.4% around 30% of reactive FTA-abs tests would be 'false-positives' if the FTA-abs test was used for screening l52.
eactivity only in the FTA-abs test must be treated with caution. An evaluation of 43 such patients found that only 3 had primary or treated syphilis, 21 (49%) had clinical and/or serological signs of yme. disease, 7 (16%) had genital herpes simplex l~ecbon, and the remaining 12 (28%)miscellaneous dlsorders l53. In the same study an isolated positive FTA-abs reaction was found in 43% (13/30) of control patients with Lyme disease.
The degree of reactivity in a subjective test such as the FTA-abs is also important and can have a very significant effect on the utility of the test. Borderline reactions are common and in the United States it has been recommended that the borderline report should be eliminatedlS. This change increased the specificity of the test from 82.5% to 88.7% but Young 
decreased the sensitivity from 100% to 99.5%152. In an evaluation of 4 commercial FTA-abs kits, discounting borderline reactions resulted in a sensitivity of up to 100% with VDRL positive sera, but when VDRL negative treponemal sera were included sensitivity ranged from 74% to 9O%ISO. These findings suggest that if the CDC recommendations are applied to sera selected on the basis of screening by a treponemal test such as the TPHA (or EIA) then a significant number of treponemal sera will fail to be confirmed. This is because the TPHA is more sensitive than the FTA-abs (except during the 3rd to 4th week of infection)?'. As expected there is a decrease in specificity when borderline reactions are scored positive. Specificity varied from 52% to 83% when borderline reactions were scored positive and from 71% to 96% when they were scored negative lSO. When the TPHA is used for screening this is not a major problem as the TPHA is the most specific method for the detection of antibody to T. pallidum, with false reactivity as low as 0.07%99. False reactivity in the FTA-abs, however, was significantly associated with false reactivity on screening with EIAISO suggesting that other tests may be more suited to confirming the treponemal nature of sera reactive on screening by EIA. Interestingly, a correlation between unexplained reactivity in the FTA-abs and ErA was noted by Veldkamp 
EIA
Although the Bio-EnzaBead test has been recommended as a suitable alternative to the FTA-abs test I21,l54,155 it lacks sensitivity in VDRL negative sera and would not be suitable for confirming sera detected by screening with treponemal antigen tests. The Captia Syphilis G EIA has also been recommended as a confirmatory test l23. This test has high sensitivity in the case of VDRL negative sera and is therefore better suited to confirming the treponemal nature of sera selected by treponemal antigen tests. However, the potential for automation endows EIA with greater advantages in a screening rather than a confirmatory role.
TPHA
The TPHA test is simple to perform and would make a good alternative to the FTA-abs, particularly with regard to sera screened by EIA. All 72 cases of treated syphilis and 93 of 96 (98.3%) cases of untreated syphilis evaluated by Lefevre et al. 123 were positive in both the TPHA and Captia Syphilis G: 3 sera from primary stage infection were positive by TPHA but negative by EIA. TPHA reactivity may be variable in primary syphilis and of 60 EIA positive sera the only one that would not have been confirmed by the TPHA was from a case of untreated primary infection 34 • EIA positive TPHA negative sera should be tested for specific antitreponemal IgM in order to exclude an early untreated primary infection. 
Immunoblotting
Immunoblotting was appreciated as a potential diagnostic method as early as 1985 156 • Recent reports 35,157 support its value as a confirmatory test although further evaluation is required in order to define the most suitable criteria for designating a positive result. Antibodies against a 15.5 kO antigen were demonstrated in 97% (107/110) of documented cases of syphilis: reactivity was 100% of patients with secondary or early latent syphilis, both untreated and treated, 98.3% in those with late latent treated syphilis and 100% in patients with neurosyphilis-". Positive blots for the 15.5 kO antigen were also obtained with 99% of 294 cases of serologically diagnosed syphilis of undetermined stage. This was a highly stringent test of sensitivity as the sera from late latent treated cases contained 8 specimens that were FTA-abs and TPHA negative. The sera from staged cases that were negative on blotting comprised 2 cases of seronegative primary infection and one case of late latent treated syphilis. The sensitivity of the test for primary syphilis was improved by using anti-human IgM conjugate rather than anti-IgG. Antibodies against the 15.5 kD antigen were absent in 47 patients with false positive reactions for syphilis and in 121 healthy blood donors-'.
Byrne et al. 157 
Response to treatment Cardiolipin antigen tests
Because there is no microbiological 'test for cure' patients treated for syphilis are assessed by serial quantitative non-treponemal tests such as the VORL or RPR5,115. All cardiolipin antigen tests tend to become negative after treatment, particularly in early syphilis while the rate of decline in titre depends on the stage of infection, the initial titre, and the history of previous syphilis-". In interpreting a fall or rise in titre a 4-fold change is considered significant but a 2-fold change is not. for many years. . Recently, Lukehart''P highlighted invasion of the central nervous system by T. pallidum in 40% of patients with early syphilis, and the failure of benzathine penicillin G to provide treponemicidal levels in the CSF after standard therapy in both lllVinfected and uninfected patients as important questions to be addressed in relation to 'test of cure'. Studies were advocated to examine rates of titre decline and seroreversal after therapy with singledose benzathine penicillin G compared with regimens known to eradicate T. pallidum from the central nervous system in both HIV-infected and uninfected individuals. Studies from the United States suggest that HIV-infected patients with primary syphilis when compared with lllV-negative controls were less likely to have a 4-fold or greater RPR decrease or seroreversion within 6 months of treatment'". A preliminary study from London'" found that serological responses after treatment tended to be preserved in lllV-infected patients. It is not dear whether these differences result from different treatment regimens or from the fact that the London patients were in the early stages of lllV infection. Clearly more data are needed.
EIA for anti-treponemal IgM
An appreciable decrease in specific IgM may be interpreted as evidence of therapeutic success?'.
Lefevre et a1. 123 considered simultaneous measurement of IgG and IgM antibodies for T. pallidum by the Captia EIAs was an efficient and simple method of confirming the diagnosis of syphilis as well as for indicating whether active disease was present. There was a good correlation between the IgM capture EIA and the 19S(IgM) FTA-abs with respect to reactivity of sera from treated patients. Although EIA was considered to be as effective as the 19S(IgM) FTA-abs test in monitoring the effect of treatment there was no serial data to support this view. Ijsselmuiden et al. 16O followed the course of anti-treponemal IgM reactivity after treatment of 6 patients for early infectious syphilis. The quantity of IgM antibody declined in nearly all patients after treatment but remained detectable in 5 patients up to 6 months after treatment: the VORL test became negative in 4 of the 6 patients within 5 months of treatment. Detection of specific IgM by EIA was not recommended as a replacement for the VORL test to monitor patients treated for syphilisl'".
TPHA
Although a rapid fall in TPHA titre may occur after treatment for secondary syphilis, the TPHA is of little help in monitoring the efficacy of treatment.
A significant rise in titre may indicate reinfection and provides a safeguard against missing reinfection as a result of a false negative VDRL reaction due to the prozone phenomenon. Because the TPHA remains positive, usually for life in non-HIV infected patients who have been adequately treated, its usẽ and that of other specific tests) for screening has increased the need for tests to provide guidance on activity of infection.
Activity of infection
Quantitative VDRL testing is to some extent useful in assessing treatment status as titres >16 are rarely found in adequately treated infections'". In theory, t~sts to detect specific IgM should provide a more direct indication of treatment status and response to therapy. Detection of specific anti-treponemal IgM, in patients without a history of recent treatment, suggests active disease and the need for chemotherapy. In general, the titres of specific IgM decline after adequate treatment of early syphilis and reactivity ceases within 3-9 months; reactivity may be found from 1 to 1.5 years after treatment of late disease?', The many methods available for detecting anti-treponemal IgM are discussed in detail elsewhereĨ mmunofluorescence with the IgM fraction of serum obtained by gel filtration or ultracentrifugation, the 19S(IgM) FTA-abs test, is considered the reference method. Failure to separate IgG and IgM fractions adequately can lead to false-positive results due to rheumatoid factors and false-negative results due to competitive inhibition of IgM binding by IgG antibodies of the same specificity for the binding site on the antigen. Separation of the IgM fraction is, however, technically demanding making SImpler procedures desirable.
The immunoglobulin M solid phase haemadsorption test, (lgM)-SPHA, was one of the first specific anti-treponemal IgM tests that was simftle and cheap enough to be applied on a large scale 61. In this test microtitre plate wells act as solid phase for ",-chaincapture; the anti-treponemal component of the captured IgM is detected by TPHA reagents. Merlin et a1. 162 found that the sensitivity of the SPHA (96%) was comparable to that of the IgM-FTA-abs test (92%) but that the specificity of the SPHA (97.4%)was superior to that of the IgM-FTAabs test (89.6%). In this study the SPHA was not compared with the 'gold standard' as the IgM-FTAabs test was performed on whole serum using a mono-specific conjugate.
Early infection
Muller and Lindenschmidt'P found that the SPHA gave false negative results in more than half of patients with untreated primary syphilis and in just over a quarter of patients with untreated secondary and late infection. Poor sensitivity of the SPHA in primary syphilis has been noted by others 164.165 and is a major drawback in the use of the test as (11113) and 64% (9/14) for primary, secondary and early latent infection, respectively. The 19S(lgM)-FTA-abs test was reactive in all primary and secondary cases and in 79% of early latent cases. High sensitivity (100%)was found for the Captia Syphilis M and 19S (lgM)-FTA-abs tests when applied to 51 cases of primary, secondary, or early latent infection l66. Both tests were reactive in two sera before the screening tests (VDRL and TPHA) supporting a role for EIA for anti-treponemal IgM in suspect early primary infection. The SPHA was reactive in only 35% of the 51 patients.
All 9 patients with primary or secondary syphilis diagnosed in Edinburgh in recent years were Captia Syphilis M positive compared with only 3 of 5 patients with early latent infection103. The two patients with early latent infection and negative IgM results had received antibiotics on at least one occasion in the two years preceding the diagnosis. Previous exposure to antibiotics combined with the general decrease in the spectrum and strength of antibody response which occurs with increased duration of infection100 may contribute to poor sensitivity in late infection. 166 . There are no clear reasons for these differences.
Late infection
Re-infection
The Captia Syphilis M test showed poorer sensitivity 53% (8/15) 
Comment
In patients with positive serological tests who lack a history of recent adequate treatment, a reactive anti-treponemal IgM test supports the need for treatment. Occasionally, however, the sera of patients who have been adequately treated will contain 8S IgM that may react in assays where immunoglobulins are not fractionated before testing l 6!,"170 . Untreated or inadequately treated infections, particularly beyond the early stages, as well as reinfections, cannot be excluded reliably on the basis of a negative anti-treponemal IgM test, and due consideration must be given to clinicalfindings, the history of the patient, and quantitative VDRL and TPHA tests. Little is known of the antitreponemal IgM response in patients with coexisting HIV and this merits detailed study. New recombinant antigen tests such as the TmpA EIA may have a role in detecting active infection as well as monitoring the success of antibiotic treatmentl-s.
NEUROSYPHILIS
Neurosyphilis includes the clinical entities of asymptomatic neurosyphilis, acute syphilitic meningitis, cerebrovascular neurosyphilis, paretic neurosyphilis, and tabes dorsalis171. Because invasion of the central nervous system can be detected before symptoms develop, and because the early effects of syphilis on the system can often be reversed by penicillin treatment, examinations of the CSF are important in the assessment of patients with syphilis. Invasion of the CSF is not unusual in early infection and by using the rabbit infectivity test (RIT) T. pallidum was found in 30% (12/40) patients with untreated primary or secondary infection-l. Concurrent infection with HIV was not associated with isolation of T. pallidum, increased numbers of CSF abnormalities, or reactive CSF serological tests for syphilis, although CSF pleocytosis was more common in HIV-infected patients.
The WHO recommendations for treatment of syphilis are that a minimal benzyl penicillin concentration of 0.018 mg/l of serum should be maintained for 7-10 days in early syphilis; and penicillin-free or subtreponemicidal intervals should not exceed 24-30 hours 172 • The CDC recommendation for the treatment of early syphilis with a single intramuscular (i.m.) injection of 2.4 million units of benzathine penicillin G is not followed by the Massachusetts Department of Public Health whose approach is an i.m. injection of 2.4 million units benzathine penicillin G given once a week on two consecutive weeks 173 • Despite the recent CDC endorsement of treatment by a single injection 45 Musherv" considered that 3 doses of benzathine penicillin, 2.4 million units at weekly intervals, is probably the minimum accepted dosage for primary or secondary infection. Practice in the UK and Europe has favoured more prolonged treatment for early syphilis, ef 900 mg procaine penicillin daily for 10-14 days'? . Penicillin at conventional doses does not yield tre~onemicidal levels in the central nervous system! -180 and probably does not eradicate the infecting organisms, suggesting that it works synergistically with the host's immune response in preventing neurosyphilisw'.
Recently a number of case reports, mainly from the USA, have described the development of neurosyphilis in patients previously treated for early syphilis18,60,174,18~suggesting that HIV infection may alter the natural course of syphilis because of its profound effect on cell mediated immunity. Whilst the immunobiology of syphilis supports these concerns Jordan183 questioned whether there was sufficient evidence to support the view that neurosyphilis was occurring in these patients with unexpected frequency, an unusually short period of latency, increased severity, and a reduced responsiveness to penicillin therapy. Ruflj15 in 1989 commented that so far there was no statistical evidence to prove the relationship between HIV infection and increased frequency of neurosyphilis. There have been several reports (reviewed in reference'P') of neurosyphilis occurring after appropriate therapy in normal hosts. HIV-infection has undoubtedly increased awareness, probably also the frequency, of a phenomenon that was already recognized 185 . The more prolonged treatments used in the UK may tip the synergistic balance in favour of the host with regard to elimination of T. pallidum, even in those patients with an immunological deficit.
Who should be tested?
In the case of patients with syphilis of uncertain duration or in the late symptomatic or late latent stage, CSF examination should be undertaken before treatments. CSF examination should precede and guide treatment of HIV infected patients with latent syphilis present for longer than one year or for unknown duration'". It has been suggested that if CSF examination is not possible, patients should be treated for presumed neurosyphilis?'. Hookl", however, stated that the policy to treat empirically all HIV-infected patients who have syphilis with high-dosage therapy effective for neurosyphilis was of unproven benefit, expensive and time-consuming for both patients and health care providers. DunlOpl86 considered that probenecid with penicillin or amoxycillinshould be as effectivein the treatment of neurosyphilis, provided treponemicidal levels are produced and maintained, as the more complicated intravenous regimens. According to Musherl'".
ore intensive diagnostic evaluation, perhaps mcluding routine cerebrospinal fluid (CSF) analysis, more intensive therapy, and far more rigorous follow-up are indicated in HIV-infected patients with syphilis. When there is evidence of clinical relapse or a 4-fold rise in titre of follow-up tests CSF examination should also be undertakenl'".
It is unnecessary to perform routine screening tests for syphilis on the CSF of patients with symptoms referrable to the central nervous system in whom there is no suspicion of syphilis. A n~gative T. pallidum antigen test on serum will Virtually exclude active neurosyphilis and is a better screen for all forms of late syphilis than examination of the CSF188. The latter should be reversed for cases selected on clinical grounds and backed by a positive TPHA on serum. It was suggested recently that a serum TPHA titre of > 2560 should be considered as a criterion when selectin~patients (non HIV-infected) for CSF examination! . If a titre of 1280was taken as the cut-off to allow for a safety margin this policy would still have reduced the number of lumbar punctures performed by 68%-the authors considered that apart from eliminating any potential risk to the patient there would have been a substantial financial saving as the cost of a lumbar puncture has been calculated at around 600 dollars. Perhaps a more conservative cut-off titre of .>640 should be applied initially as in one s~nesl90 of 45 patients with active neurosyphilis htres were 640(1),1280 (1),2560 (4) and >5120 (39) . Neurosyphilis should be considered in the differential diagnosis of neurological disease in anyone with HIV infection.
Exclusion of neurosyphilis
A negative T. pallidum antigen test on CSF virtually excludes neurosyphilis while it is most improbable at serum or CSF titres below 320 190. A negative cardiolipin test (VDRLlRPR) on the other hand does n~t exclude neurosyphilis as 30% to 57% of patients with active neurosyphilis will give a negative result on CSF examination". More recent studies support the view that the CSF VDRL is under-sensitive in neurosyphilis191-193. In contrast Jordan l 83 in a critical review of some of the studies on neurosyphilis suggested that the CSF VDRL test is the most appropriate diagnostic test. Detailed analysis involving parameters other than serological tests found the CSF VDRL non-reactive in 20% (9/45) of patients with neurosyphilisl'".
Confirmation of neurosyphilis
According to the WH04 the traditional criteria for involvement of the CNS in syphilis, viz a positive VDRL test, pleocytosis, and an increased concentration of protein in the CSF are of limited value. Although the CSF-VDRL is under-sensitive in neurosyphilis a reactive test is strongly suggestive of neurological involvement. Luger 190 reported reactivity in only 6% ( Quantitative TPHA test on CSF combined with albumin, IgG, and IgM estimations are helpful in suggesting synthesis of T. pallidum specific IgG and in excluding errors that may arise from disturbed function of the blood/CSF barner?'. Details of the various methods and expected values are reviewed elsewhere 4,5,86.190,196 but they include: defining the normality or degree of impairment of the blood/CSF barrier by the ratio of CSF to serum albumin (the albumin quotient); evidence of the local production of IgG, IgM and treponemallgG by estimating the ratio of the CSF to serum IgG concentration/the albumin quotient (the IgG index); the ratio of the CSF to serum IgM concentration/the albumin quotient (the IgM index); the ratio of CSF TPHA titre to albumin quotient (TPHA index); or by detecting oligoc1onal immunoglobulin bands in the CSF.
Neurosyphilis is most probable at a TPHA index between 70 and 500 and is strongly suggested at values above 500 190: the previous upper limit for normal of 100missed 3 cases of neurosyphilis giving a sensitivity of 93% (42/45) . Whilst several values from patients without neurological involvement approached 70 the specificity remained at 100% (67/67) when 70 was taken as the cut-off. An increased IgG or IgM index, or both, was found about 70 times more often in symptomatic neurosyphilis than in latent syphilis without involvement of the central nervous system'?", An increased IgG index together with a cell count > 5/ILI was only found in neurosyphilis but was undersensitive (sensitivity 62%). In the study by van Eijk and colleaguesl'" the IgG index gave a sensitivity of 62% (13/21) in neurosyphilis and was more sensitive than the albumin quotient (38%), >5 cells/sl (19%), IgM index (29%), and oligoclonal immunoglobulins (43%). The intrathecal T. pallidum antibody (ITPA) index (ratio of CSF to serum TPHA titres/mg total IgG) demonstrated production of antibodies within the CNS in 95% of patients with neurosyphilis. The ITPA index was also raised in 25% of patients with early and 28% with late syphilis who did not have any neurological deficit: the significance of these findings is unclear.
A review of clinical and laboratory data for 9 HIVinfected patients with symptomatic neurosyphilisl" found 7 had a reactive CSF-VDRLtest (8 of 9 tested a reactive serum VDRLlRPR test) and concluded that most, if not all, HIV-infected patients with symptomatic neurosyphilis will have elevated serum and CSF syphilis serology. Whilst acknowledging that their numbers are small, and that further experience is necessary, their conclusion that a negative serum VDRLlRPR screening test may rule out neurosyphilis in an HIV-infected patient with CNS symptomatology should be treated with caution.
Fortunately the number of cases of neurosyphilis remains low. Nevertheless there would appear to be a need for multi-centre collaborative studies based on the examination of CSF by an accepted range of tests performed in a standardized manner. Reagent kit inserts normally refer to specimens of serum or plasma but not CSF in their recommended protocols. In one study193 a CSF-TPHA dilution of 1: 4 (serum normally 1: 19) or more was taken as positive while the CSF-FTA-abs was performed at a 1; 5 dilution as for serum but in phosphate buffered saline rather than sorbent. Others have used the same methods for the VDRLand FTA-abs when evaluating both serum and CSF198.
CONGENITAL INFECTION
Attention has already been drawn to the marked increase in congenital syphilis in the USA and this has highlighted the need for appropriate surveillance and diagnostic tests: guidelines and case definitions have been published 145, 199 . Challenges relating to improved serodiagnosis and a better understanding of the immunology and pathogenesis of congenital syphilis have also been reviewed-?'. The impact of congenital sYfohilis on third world countries remains dramatic 01: rates as high as 3200/100 000 live births have been reported in Addis Ababa; in Zambia 8.6% of infants less than 3 months admitted to hospital and 7.5% of neonates admitted to intensive care units had congenital syphilis; and in Ethiopia syphilis was the 4th most common cause of perinatal death accounting for 10% of the approximately 70 perinatal deaths per 1000 live births and nearly 5% of all postneonatal deaths. Since IgM is not transferred across the placenta the demonstration of specific anti-treponemal IgM by the 195 (IgM)-FTA-abs test confirms a diagnosis of congenitaf infection. This test is not widely available, however, and is considered ex£erimental rather than a standard laboratory test! .
EIA
The Captia Syphilis M EIA appears to be a simple and useful method to detect congenital syphilis: it was reactive in all 6 reported cases of congenital infection (5 160 and 1 123) but not in 31 infants (21 160 and 10 123 ) of mothers adequately treated before or during pregnancy: all of the infants had evidence of transplacental antibody detected by the TPHA, EIA-IgG or FTA-abs. Because this test uses a tracer complex instead of an IgG class conjugate IgMrheumatoid factor should not interfere 16O. Rheumatoid factor is so common in congenital syphilis that a positive latex test for rheumatoid factor on infant's serum, in the presence of maternal syphilis, strongly suggests congenital infection 202. IgM rheumatoid factor measured by EIA was found in 92% of infants with congenital syphilis and elevated levels correlated with liver and renal involvement as well as the extent of the disease.
Immunoblotting
Immunoblotting using anti-human IgM conjugate to detect binding of anti-treponemal IgM to treponemal antigens is also of potential value in diagnosis. Sera from 5 congenitally infected infants with symptoms were shown to react differently from that of control infants born to normal, serofast, and biologicalfalse positive mothers's. IgM antibody to the 47 and 37 kD antigens was found only in sera from infected infants. Serum from an asymptomatically infected infant had a response to the 47 kD antigen but not the 37 kD antigen. The importance of the 47 kD antigen as a marker for the diagnosis of con~enital infection has been confirmed by others 3,203. Lewis et al. 37 made a more stringent interpretation of a positive blot. A typical pattern of IgM reactivity in infected infants was directed against the 47, 17 and 15.5 kD antigens with a variety of activities against the other low-molecular weight proteins. IgM reactivity was frequently seen against the 45 and 37 kD antigens and less often against the 42, 34.5, 31, and 24 kD antigens. The presence of at least 5 visually distinct IgM reactions (including specifically the 47, 17, and 15.5 kD antigen bands) was considered a reactive blot. Based on these criteria sera from 92% (23/25) of symptomatic infants diagnosed with congenital syphilis yielded positive reactions. Sera from 80 asymptomatic infants considered at risk of developing symptomatic infection were also tested and 16 exhibited IgM reaction patterns consistent with those seen in congenital infection, although in 5 cases the reactions were equivocal. On re-testing the 16 specimens using the IgM fraction obtained by serum fractionation the 5 equivocal reactors gave negative blots while the other 11 remained positive. The test was considered to be an excellent confirmatory test for congenital syphilis with superior sensitivity and specificity to the 19S (IgM)-FTA-abs test.
Serial testing of potentially infected infants is important; in the absence of infection, passively transferred antibody detected by both cardiolipin and T. pallidum antigen tests will become negative in a time period related to the initial titre, the halflife of IgG (18-23 days) and the relative sensitivity of the tests-even very high initial titres of transplacental antibody should disappear within 6 months. Serial examinations are also recommended because of the possibility that specific IgM may not be detectable until several weeks after birth due to sUppression of neonatal IgM synthesis by high levels of circulating maternal anti-treponemal IgG204.
Congenital and acquired syphilis may be difficult o distinguish when a child is seropositive after Infancy. Signs of congenital syphilis may not be obvious and stigmata may not have developed. Data on specific anti-treponemal IgM in late stage congenital infection is inadequate.
THE POLYMERASE CHAIN REACTION (PCR)
PCR can selectively amplify the copy number of a target gene more than 10 6-fold and has the theoretical ability to detect a single organism 205 ,206 . !?etection of T. pallidum DNA in body fluids and tIss~es by PCR has been investigated as a means of improving the diagnosis of congenital and neurosyphilis, conditions where serology is difficult to interpret, as well as early syphilis when a serological response may not have had time to develop. PCR is highly specific with regard to a wide range of organisms including B. burgdorferi, skin organisms, SID and CNS pathogens 39 ,207 . The PCR tests used so far will not differentiate between T.
pallidum subspecies pallidum and the closely-related T: pallidum subspecies pertenue and is of no help in differentiating between yaws and syphilis.
Although PCR has demonstrated that there might be~tendency for these two subspecies to differ in a Single base pair in the TpF1-(pallidum) and TyFl-(pertenue) encoding genes it is unlikely to be a reliable differential characteristic for either subspecies 208 • Neurosyphilis Hay and colleagues 38 ,207 performed the PCR separately with two sets of 21 base primers to detect Table 2 ). Specimens of CSF were investigated and were scored positive only if both DNA sequences were detected. The CSF from 53% (10/19) patients with positive serological tests for syphilis who were being investigated for late syphilis were DNA-positive compared with only 3% (1/30) of patients with no known history of syphilis. The 10 DNA-positive patients comprised neurosyphilis (2) , possible asymptomatic neurosyphilis (1), and latent syphilis (7) . CSF from 28 HIV-positive patients were also tested. Fourteen of these patients had CNS disease and 7 were DNA-positive, whereas none of the 14 without CNS disease were DNA-positive. Five of the 7 DNA-positive patients had a history of syphilis giving a total reactivity of 58% (15/26) in patients with a history of syphilis. DNA equivalent to about 65 treponemes in 0.5 ml of CSF were required to give a positive reaction which could account for the relatively low sensitivity with clinical specimens.
The occurrence of treponemal DNA in CSF was also investigated by PCR amplification of a 617 base pair fra~ent of the 39 kD bmp gene of T, pallidum . Although purified T. pallidum DNA equivalent to a single organism could be detected the method was less sensitive when applied to CSF: after concentration using diatomaceous earth it was possible to detect about 100 treponemes in 1 ml of CSF. Prior to penicillin treatment T. pallidum DNA was detected in 71% (5/7) of patients with acute neurosyphilis, in none of 4 patients with chronic symptomatic neurosyphilis tested before treatment, and in 12.5% (2/16) of patients with asymptomatic neurosyphilis. These results may represent an underestimate of the sensitivity of PCR as the CSF specimens were collected in the pre-PCR era and were stored without special care to avoid degradation of DNA.
Unexpectedly DNA was often detected in CSF long after intravenous treatment with penicillin; in one case after 3 years. It would seem that the detection of T. pallidum DNA by PCR is of limited value in checking the efficacy of treatment for patients with neurosyphilis. DNA is a very stable biopolymer and may remain present in CSF for long periods of time after the killi~g of T. pallidum by intravenous penicillin therapy". Sensitivity in primary syphilis- Figure 2 With untreated patients the Captia Syphilis G is the most sensitive although there is very little difference between the various tests. Whereas all of the 75% (6/8) and 63% (5/8) when tested on the day of collection compared with 83% (10/12) and 10% (1/10) when stored for 60 days before testing.
The specificity of PCR, particularly with regard to early lesions, is of great importance in view of reports that pathogen-related spirochaetes, that cause necrotizing ulcerative gingivitis 95.96, react with monoclonal antibodies once considered to be pathogen specific (T. pallidum subspecies pallidum and T. pallidum subspecies pertenue 28 ) .
RECOMBINANT ANTIGENS
The production of specific T. pallidum protein antigens in Escherichia coli is ethically preferable to animal culture and would overcome the technical problems of producing large quantities of pure antigen from rabbit testes. Details of production and a list of the 25 or so T. pallidum recombinant antigens produced so far are given elsewhere-P, The main such antigens used in serodiagnosis are shown in Table 2 : the sequence of the majority of proteins is known and all are cell envelope associated.
Four of these antigens, P6 214, P2*215, TmpB32 and TpD216 have been evaluated to a very limited extent. The other three antigens have been evaluated more extensively and by methods suitable for screening: TmpA (a strongly antigenic exported lipoprotein) by EIA126; '37K' (function and properties not clearly defined) by radioimmunoassay (RIA)217; 4D (subunit of a 190 kD polymer able to form ring structuresv-P) by EIA218. The sensitivity of these tests in primary syphilis and latent syphilis is summarized in Figures 2 and 3 while the specificity is shown in Figure 4 . Data for the Captia Syphilis G EIA123 based on conventional T. pallidum antigen ElA are given for comparison. Data are not given for secondary syphilis as all tests approach 100% sensitivity. All of the tests described also react with sera from patients with yaws and pinta and are of no value in differentiating between these infections.
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FiRlIre 2. A PCR39 based on primers to detect sequences of the gene encoding the pathogen-specific and highc onserved 47 kD membrane immunogen, tpp47 2 was routinely positive with suspensions of treponemes calculated to contain 10 or more organisms and reactive with some suspensions calculated to contain a single organism. It was also possible to amplify T. pallidum DNA from paraffinembedded tissue. Inhibition of PCR could result from rabbit testicular tissue and human leukocytes but this could be overcome by DNA extraction'". Grimprel and colleagues-P evaluated this PCR on a variety of clinical specimens of value in diagnosing congenital infection. PCR was 100% specific for T. pallidum when compared with the rabbit infectivity test (RIT) for all clinical materials tested. PCR was 100% sensitive for seven amniotic fluids also positive by RIT; amniotic fluid is known to contain large numbers of treponemes-!'. Twenty newborns of mothers with syphilis were also investigated. Compared with RIT the sensitivity of PCR was 60% (3/5) for neonatal CSF and 67% (4/6) for neonatal sera: these specimens are likely to contain fewer organisms than amniotic fluids. It was concluded that PCR can be a useful adjunct in the diagnosis and clinical management of congenital syphilis as well as providing a valuable tool for investigating the pathogenesis of congenital infection. A large prospective study is required to compare the results of PCR with RIT, serological tests including demonstration of fetal anti-treponemal IgM, and clinical evaluation-!".
Congenital infection Early syphilis
The suitability of PCR40 for detecting DNA in various specimens in early syphilis was investigated using experimentally infected rabbits-T'. Whole blood in heparin or EDTA (but not serum), lesion exudate, and punch biopsy as well as swabs of lesions were useful specimens. DNA was detected in whole blood in 30% (3/10) of rabbits on day 4 postinfection and in 90% (9/10) on day 8: the rabbit whose blood was negative by PCR did not develop orchitis. Of 18 serum samples from rabbits whose blood was PCR positive only one (6%) gave a positive PCR result; treponemes were thought to be trapped during the clotting process. These findings are different from those of Grimprel and colleagues-!" who reported a reactive PCR in 45% (9/20) of serum specimens from neonates with congenital infection. All 36 swabs taken during the development of primary lesions at 10 and 18 days post-infection were positive including 13 kept at room temperature for 60 days in tightly sealed tubes. All 15 punch biopsy specimens of 18 day lesions were positive including seven stored at room temperature for 60 days. In the case of healing lesions (day 30 post-infection) biopsy specimens were better than swabs: relative sensitivities were TmpA Captia G primaries in the Captia evaluation were seropositive, 16% (9) of those evaluated by TmpA were seronegative and if these are excluded the sensitivitỹ ea~h~s 89%. Sensitivity of 40 in treated patients IS similar to the sensitivity of the other tests with untreated patients. However, as the sera in the 40 evaluation were taken within 3 months of treatment thi.s is not surprising. Coates and colleagues-!? usmg RIA to determine antibody to 40 antigen fo~nd~sensitivity of only 55% in 121 untreated pn~anes. The higher sensitivity with the '37K' antIgen when applied to a mixed group of treated and untreated patients is in keeping with the development of seropositivity after treatment.
S~nsitivity in early latent and late syphilis- FIgure 3 It is~ore difficult to make comparisons between tests in late syphilis because of the different composition of the patient groups. The 4D data Illustrates the decrease in sensitivity between early latent and late infection. Treatment status is an additional complicating factor. Whereas the early latent group were evaluated within 3 months of treatment, the treatment status and period since treatment were undocumented for the late latent and late active groups. This combined with the small n~mber of patients may account for the apparent hl~her. sensitivity in late latent compared with late active mfection. The '371<' data shows a similar level of sensitivity between latent (unspecified but presumed late latent) and late active infection: both categories comprised treated and untreated patients. The TmpA assay has high sensitivity in untreated early latent syphilis. As antibody to TmpA drops sharply after treatment, and in general is similar to VO~LlRPR activit y 126, it suggests low sensitivity in late mfection. In a preliminary analysis, however, We found the TmpA was reactive in 70% of 13 untreated late latent infections; VORL reactivity was 54% (unpublished data). The superiority of Captia Syphilis G in detecting infection beyond the secondary stage is clearly demonstrated.
It may be that diagnostic reagents suitable for scr~ening will require a pool of several recombinant antigens. Appropriate single antigen tests may then be used to help assess the stage of infection: eg P2*215 was shown by immunoblotting to have superior reactivity in primary (5/6) compared with secondary (1/5) and latent (0/6). We also need more information on antibody responses to single recombinant antigen tests during re-infection before they are considered for adoption as first line screening tests.
Specificity of recombinant antigen tests- Figure 4 In theory, pathogen specific recombinant antigen tests should have higher specificity than tests based on sonicated T. pallidum prepared from rabbit testes. However, as a significant proportion of the population contains serum antibodies against antigens of the E. coli outer envelope, recombinant antigens must be stringently purified to remove E. coli proteins. The 4D antigen EIA was 100% specific when tested against 172 VORL negative and 20 BFP sera. Using RIA about 3% of 118 normal sera were reactive/!". The '37K' antigen reacted with 9.5% (4/42) BFP sera and 4.6% (3/65) normal sera. TmpA reactivity was found in 0.4% (4/938) blood donors and 1.6% (3/190) STO clinic patients (all VORL. TPHA and FTA-abs negative). We have now evaluated approximately 58,500 sera by Captia Syphilis G and found 1.1% (643/57,830) of patients subsequently shown to be non-infected (VORL and TPHA negative) had an antibody index > 0.9 on screening; 0.8% (477/57,830) of the patients were confirmed as false positives (antibody index> 1.0) on re-testing the same specimen. The mean antibody index for false-positive sera was 1.26 compared with 2.72 for VORL positive and 1.80 for VORL negative treponemal sera. These false positive reactions were not associated with any specific condition-s'. Recently Lefevre and colleagues confirmed the overall high specificity of the Captia Syphilis G test but found it was reactive with 30% (6/20) of sera from patients with Lyme borreliosis-".
The theoretical specificity of recombinant antigen tests has not been proved in practice, even in relatively small scale research evaluations. Further difficulties will be experienced in 'scaling-up' tests to large scale commercial production levels required for use in routine diagnostic laboratories. For example in a preliminary evaluation of TmpA we obtained a specificity of 100% on testing 40 noninfected STO clinic patients; in a later large scale evaluation the sensitivity decreased to 93%(558/601) when evaluating all sera requiring serological tests for syphilis. This value is significantly higher (P<O.Ol) than the value determined in the preliminary studies 126 ; these differences are almost certainly due to changes in antigen purification when 'scaling up' production.
CONCLUSIONS
EIAbecause of its suitability for automation and computerization is likely to be used increasingly as a single screening test. It is a highly sensitive test and should be useful in detecting evidence of past treponemal infection in HIV-infected patients. In suspect primary infection it can be supplemented by IgM testing on clinical request. Recombinant antigen EIAs are likely to gain acceptance as screening tests, particularly for early infection, although large scale purification procedures require optimization. Such tests may also have a role in treatment monitoring and in indicating treatment status. Limitationsof the FrA-abs are becoming increasingly recognized particularly when treponemal antigen tests are used for screening. There appears to be a correlation between false reactivity in EIA and the FTA-abs tests. New confirmatory approaches such as immunoblotting are required to complement screening by EIA. EIA for anti-treponemal IgM is of value in determining treatment status in early infection and in diagnosing congenital infection in the newborn. More sensitive IgM tests are required to help assess treatment status in late infection. In view of the interactions between syphilis and HIV infection, all aspects of syphilis serology must be carefully monitored in coinfected patients. The significance of CSF abnormalities requires especially detailed clinical and laboratory appraisal. PCR should over the next few years increase our understanding of treponemal pathogenesis, particularly in HIV infected patients. Its role in diagnosis, however, remains to be established and results should be treated in the context of research data. Perhaps the most important factor at present is to make the best use of our existing technology and ensure that reliable testing is delivered to the populations at risk.
